Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying Zou

Showing results (611-620 of 614) with videos related to

Pageof 62
Sort By:
You have reached the last page of results.This site can display upto 614 results.
Journal of Affective Disorders|July 26, 2011
Age at onset of major depressive disorder in Han Chinese women: relationship with clinical features and family historyFuzhong Yang, Yihan Li, Dong Xie, et al.
Nature|June 14, 2019
Atypical behaviour and connectivity in SHANK3-mutant macaquesYang Zhou, Jitendra Sharma, Qiong Ke, et al.
Blood Cancer Discovery|September 25, 2020
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on <i>MIR300</i> Antiproliferative and PP2A-Activating FunctionsGiovannino Silvestri, Rossana Trotta, Lorenzo Stramucci, et al.
The World Allergy Organization Journal|December 22, 2021
Expert consensus on the use of omalizumab in chronic urticaria in ChinaZuotao Zhao, Tao Cai, Hong Chen, et al.
Pageof 62

Showing results (611-620 of 614) with videos related to

Sort By:
Pageof 62
You have reached the last page of results.This site can display upto 614 results.
Journal of Affective Disorders|July 26, 2011
Age at onset of major depressive disorder in Han Chinese women: relationship with clinical features and family historyFuzhong Yang, Yihan Li, Dong Xie, et al.
Nature|June 14, 2019
Atypical behaviour and connectivity in SHANK3-mutant macaquesYang Zhou, Jitendra Sharma, Qiong Ke, et al.
Blood Cancer Discovery|September 25, 2020
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on <i>MIR300</i> Antiproliferative and PP2A-Activating FunctionsGiovannino Silvestri, Rossana Trotta, Lorenzo Stramucci, et al.
The World Allergy Organization Journal|December 22, 2021
Expert consensus on the use of omalizumab in chronic urticaria in ChinaZuotao Zhao, Tao Cai, Hong Chen, et al.
Pageof 62